{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,12]],"date-time":"2025-12-12T12:08:10Z","timestamp":1765541290431,"version":"3.48.0"},"reference-count":92,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,10,7]],"date-time":"2025-10-07T00:00:00Z","timestamp":1759795200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,10,7]],"date-time":"2025-10-07T00:00:00Z","timestamp":1759795200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"DOI":"10.13039\/501100004587","name":"Ministry of Economy and Competitiveness | Instituto de Salud Carlos III","doi-asserted-by":"publisher","award":["PI18\/00053"],"award-info":[{"award-number":["PI18\/00053"]}],"id":[{"id":"10.13039\/501100004587","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004587","name":"Ministry of Economy and Competitiveness | Instituto de Salud Carlos III","doi-asserted-by":"publisher","award":["PI18\/00053"],"award-info":[{"award-number":["PI18\/00053"]}],"id":[{"id":"10.13039\/501100004587","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Mol Psychiatry"],"published-print":{"date-parts":[[2026,1]]},"DOI":"10.1038\/s41380-025-03287-4","type":"journal-article","created":{"date-parts":[[2025,10,7]],"date-time":"2025-10-07T07:39:25Z","timestamp":1759822765000},"page":"362-373","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Differential effect of cannabis use and antipsychotic medication on extracellular free-water in the brain of individuals with early psychosis and controls"],"prefix":"10.1038","volume":"31","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-8693-8902","authenticated-orcid":false,"given":"Laura","family":"Mart\u00ednez-Sadurn\u00ed","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marta","family":"Barrera-Conde","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Patricia","family":"Robledo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Emma","family":"Veza-Estevez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jordi","family":"Garcia-Quintana","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2127-349X","authenticated-orcid":false,"given":"Anna","family":"Man\u00e9","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alba","family":"Toll","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Amira","family":"Trabsa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6160-3927","authenticated-orcid":false,"given":"Tyler A.","family":"Lesh","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Cameron S.","family":"Carter","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Daniel","family":"Berg\u00e9","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2025,10,7]]},"reference":[{"key":"3287_CR1","doi-asserted-by":"crossref","first-page":"1135","DOI":"10.1016\/S0140-6736(20)31404-5","volume":"396","author":"GBD 2019 Diseases and Injuries Collaborators","year":"2020","unstructured":"GBD 2019 Diseases and Injuries Collaborators. Global burden of 369 diseases and injuries in 204 countries and territories, 1990\u20132019: a systematic analysis for the Global Burden of Disease Study 2019. Lancet. 2020;396:1135\u201359.","journal-title":"Lancet"},{"key":"3287_CR2","doi-asserted-by":"crossref","first-page":"635","DOI":"10.1016\/S0140-6736(09)60995-8","volume":"374","author":"J Van Os","year":"2009","unstructured":"Van Os J, Kapur S. Schizophrenia. Lancet Psychiatry. 2009;374:635\u201345.","journal-title":"Lancet Psychiatry"},{"key":"3287_CR3","doi-asserted-by":"publisher","first-page":"421","DOI":"10.1038\/nature13595","volume":"511","author":"S Ripke","year":"2014","unstructured":"Ripke S, Neale BM, Corvin A, Walters JTR, Farh KH, Holmans PA, et al. Biological insights from 108 schizophrenia-associated genetic loci. Nature. 2014;511:421\u20137.","journal-title":"Nature"},{"key":"3287_CR4","doi-asserted-by":"publisher","first-page":"729","DOI":"10.1093\/schbul\/sbu069","volume":"40","author":"J Van Os","year":"2014","unstructured":"Van Os J, Rutten BP, Myin-Germeys I, Delespaul P, Viechtbauer W, Van Zelst C, et al. Identifying gene-environment interactions in schizophrenia: contemporary challenges for integrated, large-scale investigations. Schizophr Bull. 2014;40:729\u201336.","journal-title":"Schizophr Bull"},{"key":"3287_CR5","doi-asserted-by":"publisher","first-page":"235","DOI":"10.1016\/j.euroneuro.2020.03.003","volume":"36","author":"S Arranz","year":"2020","unstructured":"Arranz S, Man\u00e9 A, Berg\u00e9 D, Monserrat C, Vilella E, Sanchez-Gistau V. The impact of sex and cannabis on clinical features in first \u2013 admitted patients with psychosis. Eur Neuropsychopharmacol. 2020;36:235\u201343.","journal-title":"Eur Neuropsychopharmacol"},{"key":"3287_CR6","doi-asserted-by":"publisher","first-page":"1262","DOI":"10.1093\/schbul\/sbw003","volume":"42","author":"A Marconi","year":"2016","unstructured":"Marconi A, Forti M, Di, Lewis CM, Murray RM, Vassos E. Meta-analysis of the association between the level of cannabis use and risk of psychosis. Schizophr Bull. 2016;42:1262\u20139.","journal-title":"Schizophr Bull"},{"key":"3287_CR7","doi-asserted-by":"publisher","first-page":"690","DOI":"10.1177\/0020764018801690","volume":"64","author":"MB Ortiz-Medina","year":"2018","unstructured":"Ortiz-Medina MB, Perea M, Torales J, Ventriglio A, Vitrani G, Aguilar L, et al. Cannabis consumption and psychosis or schizophrenia development. Int J Soc Psychiatry. 2018;64:690\u2013704.","journal-title":"Int J Soc Psychiatry"},{"key":"3287_CR8","doi-asserted-by":"publisher","first-page":"549","DOI":"10.1016\/j.biopsych.2015.08.001","volume":"79","author":"SH Gage","year":"2016","unstructured":"Gage SH, Hickman M, Zammit S. Association between cannabis and psychosis: epidemiologic evidence. Biol Psychiatry. 2016;79:549\u201356.","journal-title":"Biol Psychiatry"},{"key":"3287_CR9","doi-asserted-by":"publisher","first-page":"319","DOI":"10.1016\/S0140-6736(07)61162-3","volume":"370","author":"THM Moore","year":"2007","unstructured":"Moore THM, Zammit S, Lingford-hughes A, Barnes TRE, Jones PB, Burke M, et al. Cannabis use and risk of psychotic or affective mental health outcomes: a systematic review. Lancet. 2007;370:319\u201328.","journal-title":"Lancet"},{"key":"3287_CR10","doi-asserted-by":"publisher","first-page":"38","DOI":"10.1016\/j.psychres.2017.01.045","volume":"250","author":"A Man\u00e9","year":"2017","unstructured":"Man\u00e9 A, Berg\u00e9 D, Penzol MJ, Parellada M, Bioque M, Lobo A, et al. Cannabis use, COMT, BDNF and age at first-episode psychosis. Psychiatry Res. 2017;250:38\u201343.","journal-title":"Psychiatry Res"},{"key":"3287_CR11","doi-asserted-by":"publisher","first-page":"227","DOI":"10.1176\/appi.ps.201400316","volume":"67","author":"D Berg\u00e9","year":"2016","unstructured":"Berg\u00e9 D, Man\u00e9 A, Salgado P, Cortizo R, Garnier C, Gomez L, et al. Predictors of relapse and functioning in first-episode psychosis: a two-year follow-up study. Psychiatr Serv. 2016;67:227\u201333.","journal-title":"Psychiatr Serv"},{"key":"3287_CR12","doi-asserted-by":"publisher","first-page":"2513","DOI":"10.1017\/S0033291714000191","volume":"44","author":"E Manrique-Garcia","year":"2014","unstructured":"Manrique-Garcia E, Zammit S, Dalman C, Hemmingsson T, Andreasson S, Allebeck P. Prognosis of schizophrenia in persons with and without a history of cannabis use. Psychol Med. 2014;44:2513\u201321.","journal-title":"Psychol Med"},{"key":"3287_CR13","doi-asserted-by":"publisher","first-page":"316","DOI":"10.1093\/schbul\/sbq079","volume":"38","author":"M Y\u00fccel","year":"2012","unstructured":"Y\u00fccel M, Bora E, Lubman DI, Solowij N, Brewer WJ, Cotton SM, et al. The impact of cannabis use on cognitive functioning in patients with schizophrenia: a meta-analysis of existing findings and new data in a first-episode sample. Schizophr Bull. 2012;38:316\u201330.","journal-title":"Schizophr Bull"},{"key":"3287_CR14","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1016\/j.schres.2011.02.017","volume":"128","author":"RA Rabin","year":"2011","unstructured":"Rabin RA, Zakzanis KK, George TP. The effects of cannabis use on neurocognition in schizophrenia: a meta-analysis. Schizophr Res. 2011;128:111\u20136.","journal-title":"Schizophr Res"},{"key":"3287_CR15","doi-asserted-by":"publisher","first-page":"4999","DOI":"10.2174\/138161212802884799","volume":"18","author":"A Segev","year":"2012","unstructured":"Segev A, Lev-Ran S. Neurocognitive functioning and cannabis use in Schizophrenia. Curr Pharm Des. 2012;18:4999\u20135007.","journal-title":"Curr Pharm Des"},{"key":"3287_CR16","doi-asserted-by":"publisher","first-page":"464","DOI":"10.1089\/can.2021.0163","volume":"8","author":"L Dellazizzo","year":"2023","unstructured":"Dellazizzo L, Potvin S, Gigu\u00e8re S, Dumais A. The potential paradoxical neurocognitive effects of cannabis use in patients with psychotic disorders: a critical meta-review of meta-analytical evidence. Cannabis Cannabinoid Res. 2023;8:464\u201375.","journal-title":"Cannabis Cannabinoid Res"},{"key":"3287_CR17","doi-asserted-by":"publisher","first-page":"sgae016","DOI":"10.1093\/schizbullopen\/sgae016","volume":"5","author":"TA Lesh","year":"2024","unstructured":"Lesh TA, Rhilinger J, Brower R, Mawla AM, Ragland JD, Niendam TA, et al. Using Task-fMRI to explore the relationship between lifetime cannabis use and cognitive control in individuals with first-episode schizophrenia. Schizophr Bull Open. 2024;5:sgae016.","journal-title":"Schizophr Bull Open"},{"key":"3287_CR18","doi-asserted-by":"publisher","first-page":"292","DOI":"10.1001\/jamapsychiatry.2015.3278","volume":"73","author":"ND Volkow","year":"2016","unstructured":"Volkow ND, Swanson JM, Evins AE, DeLisi LE, Meier MH, Gonzalez R, et al. Effects of cannabis use on human behavior, including cognition,motivation, and psychosis: a review. JAMA Psychiatry. 2016;73:292\u20137.","journal-title":"JAMA Psychiatry"},{"key":"3287_CR19","doi-asserted-by":"publisher","first-page":"786","DOI":"10.1016\/j.euroneuro.2019.04.005","volume":"29","author":"M Bioque","year":"2019","unstructured":"Bioque M, Mas S, Costanzo MC, Cabrera B, Lobo A, Gonz\u00e1lez-Pinto A, et al. Gene-environment interaction between an endocannabinoid system genetic polymorphism and cannabis use in first episode of psychosis. Eur Neuropsychopharmacol. 2019;29:786\u201394.","journal-title":"Eur Neuropsychopharmacol"},{"key":"3287_CR20","doi-asserted-by":"publisher","first-page":"1111","DOI":"10.1093\/schbul\/sbn108","volume":"34","author":"C Henquet","year":"2008","unstructured":"Henquet C, Di Forti M, Morrison P, Kuepper R, Murray RM. Gene-environment interplay between cannabis and psychosis. Schizophrenia Bull. 2008;34:1111\u201321.","journal-title":"Schizophrenia Bull"},{"key":"3287_CR21","doi-asserted-by":"publisher","first-page":"5024","DOI":"10.2174\/138161212802884609","volume":"18","author":"MJ Pelayo-Ter\u00e1n","year":"2012","unstructured":"Pelayo-Ter\u00e1n MJ, Suarez-Pinilla P, Chadi N, Crespo-Facorro B. Gene-environment interactions underlying the effect of cannabis in first episode psychosis. Curr Pharm Des. 2012;18:5024\u201335.","journal-title":"Curr Pharm Des"},{"key":"3287_CR22","doi-asserted-by":"publisher","first-page":"1174","DOI":"10.1093\/schbul\/sbt141","volume":"39","author":"B Kirkpatrick","year":"2013","unstructured":"Kirkpatrick B, Miller BJ. Inflammation and Schizophrenia. Schizophr Bull. 2013;39:1174\u20139.","journal-title":"Schizophr Bull"},{"key":"3287_CR23","doi-asserted-by":"publisher","first-page":"742","DOI":"10.1093\/schbul\/sby125","volume":"45","author":"D Fraguas","year":"2019","unstructured":"Fraguas D, D\u00edaz-caneja CM, Ayora M, Hern\u00e1ndez-\u00e1lvarez F, Rodr\u00edguez- A, Recio S, et al. Oxidative stress and inflammation in first-episode psychosis: a systematic review and meta-analysis. Schizophr Bull. 2019;45:742\u201351.","journal-title":"Schizophr Bull"},{"key":"3287_CR24","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1111\/acps.13416","volume":"146","author":"C Dunleavy","year":"2022","unstructured":"Dunleavy C, Elsworthy RJ, Wood SJ, Aldred S. Inflammation in first- episode psychosis: the contribution of inflammatory biomarkers to the emergence of negative symptoms, a systematic review and meta- analysis. Acta Psychiatr Scand. 2022;146:6\u201320.","journal-title":"Acta Psychiatr Scand"},{"key":"3287_CR25","doi-asserted-by":"publisher","first-page":"2512","DOI":"10.1111\/j.1476-5381.2011.01461.x","volume":"165","author":"A Juknat","year":"2012","unstructured":"Juknat A, Pietr M, Kozela E, Rimmerman N, Levy R, Coppola G, et al. Differential transcriptional profiles mediated by exposure to the cannabinoids cannabidiol and D 9-tetrahydrocannabinol in BV-2 microglial cells. Br J Pharmacol. 2012;165:2512\u201328.","journal-title":"Br J Pharmacol."},{"key":"3287_CR26","doi-asserted-by":"publisher","first-page":"177","DOI":"10.1089\/can.2020.0105","volume":"6","author":"FR Henshaw","year":"2021","unstructured":"Henshaw FR, Dewsbury LS, Lim CK, Steiner GZ. The effects of Cannabinoids on pro-and anti-inflammatory cytokines: a systematic review of in vivo studies. Cannabis Cannabinoid Res. 2021;6:177\u201395.","journal-title":"Cannabis Cannabinoid Res"},{"key":"3287_CR27","doi-asserted-by":"publisher","first-page":"6461","DOI":"10.4049\/jimmunol.164.12.6461","volume":"164","author":"TW Klein","year":"2000","unstructured":"Klein TW, Newton CA, Nakachi N, Friedman H. \u03949-Tetrahydrocannabinol treatment suppresses immunity and early IFN-\u03b3, IL-12, and IL-12 receptor \u03b22 responses to Legionella pneumophila infection. J Immunol. 2000;164:6461\u20136.","journal-title":"J Immunol"},{"key":"3287_CR28","doi-asserted-by":"publisher","DOI":"10.1016\/j.psychres.2020.113380","volume":"293","author":"CL Gibson","year":"2020","unstructured":"Gibson CL, Nia AB, Spriggs SA, Defrancisco D, Perkel C, Zhong X, et al. Cannabinoid use in psychotic patients impacts inflammatory levels and their association with psychosis severity. Psychiatry Res. 2020;293:113380.","journal-title":"Psychiatry Res"},{"key":"3287_CR29","doi-asserted-by":"publisher","first-page":"227","DOI":"10.1007\/7854_2019_91","volume":"44","author":"AK Pandurangi","year":"2020","unstructured":"Pandurangi AK, Buckley PF. Inflammation, antipsychotic drugs, and evidence for effectiveness of anti-inflammatory agents in schizophrenia. Curr Top Behav Neurosci. 2020;44:227\u201344.","journal-title":"Curr Top Behav Neurosci"},{"key":"3287_CR30","doi-asserted-by":"publisher","first-page":"68","DOI":"10.1177\/01926233231164557","volume":"51","author":"B Bolon","year":"2023","unstructured":"Bolon B. Toxicologic pathology forum opinion: interpretation of gliosis in the brain and spinal cord observed during nonclinical safety studies. Toxicol Pathol. 2023;51:68\u201376.","journal-title":"Toxicol Pathol"},{"key":"3287_CR31","doi-asserted-by":"publisher","first-page":"1229","DOI":"10.1007\/s40263-020-00765-x","volume":"34","author":"AA Dinesh","year":"2020","unstructured":"Dinesh AA, Islam J, Khan J, Turkheimer F, Vernon AC. Effects of antipsychotic drugs: cross talk between the nervous and innate immune system. CNS Drugs Adis. 2020;34:1229\u201351.","journal-title":"CNS Drugs Adis"},{"key":"3287_CR32","doi-asserted-by":"publisher","first-page":"369","DOI":"10.1016\/S0022-3956(00)00032-7","volume":"34","author":"T Pollm\u00e4cher","year":"2000","unstructured":"Pollm\u00e4cher T, Haack M, Schuld A, Kraus T, Hinze-Selch D. Effects of antipsychotic drugs on cytokine networks. J Psychiatr Res. 2000;34:369\u201382.","journal-title":"J Psychiatr Res"},{"key":"3287_CR33","doi-asserted-by":"publisher","first-page":"532","DOI":"10.1016\/j.bbi.2006.02.002","volume":"20","author":"\u0141 Drzyzga","year":"2006","unstructured":"Drzyzga \u0141, Obuchowicz E, Marcinowska A, Herman ZS. Cytokines in schizophrenia and the effects of antipsychotic drugs. Brain Behav Immun. 2006;20:532\u201345.","journal-title":"Brain Behav Immun"},{"key":"3287_CR34","doi-asserted-by":"publisher","first-page":"e009888","DOI":"10.1136\/bmjopen-2015-009888","volume":"6","author":"R Patel","year":"2016","unstructured":"Patel R, Wilson R, Jackson R, Ball M, Shetty H, Broadbent M, et al. Association of cannabis use with hospital admission and antipsychotic treatment failure in first episode psychosis: an observational study. BMJ Open. 2016;6:e009888.","journal-title":"BMJ Open"},{"key":"3287_CR35","doi-asserted-by":"publisher","first-page":"2222","DOI":"10.1038\/npp.2017.50","volume":"42","author":"NI Brzozowska","year":"2017","unstructured":"Brzozowska NI, De Tonnerre EJ, Li KM, Wang XS, Boucher AA, Callaghan PD, et al. The differential binding of antipsychotic drugs to the ABC transporter P-Glycoprotein predicts cannabinoid-antipsychotic drug interactions. Neuropsychopharmacology. 2017;42:2222\u201331.","journal-title":"Neuropsychopharmacology"},{"key":"3287_CR36","doi-asserted-by":"publisher","first-page":"717","DOI":"10.1002\/mrm.22055","volume":"62","author":"O Pasternak","year":"2009","unstructured":"Pasternak O, Sochen N, Gur Y, Intrator N, Assaf Y. Free water elimination and mapping from diffusion MRI. Magn Reson Med. 2009;62:717\u201330.","journal-title":"Magn Reson Med"},{"key":"3287_CR37","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1007\/s12031-007-0029-0","volume":"34","author":"Y Assaf","year":"2008","unstructured":"Assaf Y, Pasternak O. Diffusion Tensor Imaging (DTI) -based white matter mapping in brain research: a review. J Mol Neurosci. 2008;34:51\u201361.","journal-title":"J Mol Neurosci"},{"key":"3287_CR38","doi-asserted-by":"publisher","first-page":"761","DOI":"10.1038\/s41380-019-0428-y","volume":"26","author":"TA Lesh","year":"2021","unstructured":"Lesh TA, Maddock RJ, Howell A, Wang H, Tanase C, Daniel Ragland J, et al. Extracellular free water and glutathione in first-episode psychosis\u2014a multimodal investigation of an inflammatory model for psychosis. Mol Psychiatry. 2021;26:761\u201371.","journal-title":"Mol Psychiatry"},{"key":"3287_CR39","doi-asserted-by":"publisher","first-page":"4185","DOI":"10.1038\/s41380-023-02213-w","volume":"28","author":"TA Lesh","year":"2023","unstructured":"Lesh TA, Iosif AM, Tanase C, Vlasova RM, Ryan AM, Bennett J, et al. Extracellular free water elevations are associated with brain volume and maternal cytokine response in a longitudinal nonhuman primate maternal immune activation model. Mol Psychiatry. 2023;28:4185\u201394.","journal-title":"Mol Psychiatry"},{"key":"3287_CR40","doi-asserted-by":"publisher","first-page":"1294","DOI":"10.1016\/S0140-6736(89)91909-0","volume":"2","author":"R Buhl","year":"1989","unstructured":"Buhl R, Jaffe HA, Holroyd KJ, Wells FB, Mastrangeli A, Saltini C, et al. Systemic glutathione deficiency in symptom-free HIV-seropositive individuals. Lancet. 1989;2:1294\u20138.","journal-title":"Lancet"},{"key":"3287_CR41","doi-asserted-by":"publisher","first-page":"283","DOI":"10.1016\/j.bbi.2019.09.010","volume":"83","author":"MA Di Biase","year":"2020","unstructured":"Di Biase MA, Katabi G, Piontkewitz Y, Cetin-Karayumak S, Weiner I, Pasternak O. Increased extracellular free-water in adult male rats following in utero exposure to maternal immune activation. Brain Behav Immun. 2020;83:283\u20137.","journal-title":"Brain Behav Immun"},{"key":"3287_CR42","doi-asserted-by":"publisher","first-page":"542","DOI":"10.1093\/schbul\/sbaa134","volume":"47","author":"MA Di Biase","year":"2021","unstructured":"Di Biase MA, Zalesky A, Cetin-Karayumak S, Rathi Y, Lv J, Boerrigter D, et al. Large-Scale evidence for an association between peripheral inflammation and white matter free water in schizophrenia and healthy individuals. Schizophr Bull. 2021;47:542\u201351.","journal-title":"Schizophr Bull"},{"key":"3287_CR43","doi-asserted-by":"publisher","first-page":"557","DOI":"10.1016\/j.bbi.2023.11.006","volume":"115","author":"D Wu","year":"2024","unstructured":"Wu D, Wu Q, Li F, Wang Y, Zeng J, Tang B, et al. Free water alterations in different inflammatory subgroups in schizophrenia. Brain Behav Immun. 2024;115:557\u201364.","journal-title":"Brain Behav Immun"},{"key":"3287_CR44","doi-asserted-by":"publisher","first-page":"3587","DOI":"10.1093\/brain\/awr307","volume":"134","author":"Y Wang","year":"2011","unstructured":"Wang Y, Wang Q, Haldar JP, Yeh FC, Xie M, Sun P, et al. Quantification of increased cellularity during inflammatory demyelination. Brain. 2011;134:3587\u201398.","journal-title":"Brain"},{"key":"3287_CR45","doi-asserted-by":"publisher","first-page":"701","DOI":"10.1038\/mp.2017.43","volume":"23","author":"AE Lyall","year":"2018","unstructured":"Lyall AE, Pasternak O, Robinson DG, Newell D, Trampush JW, Gallego JA, et al. Greater extracellular free water in first-episode psychosis predicts better neurocognitive functioning. Mol Psychiatry. 2018;23:701\u20137.","journal-title":"Mol Psychiatry"},{"key":"3287_CR46","doi-asserted-by":"publisher","first-page":"846","DOI":"10.1093\/schbul\/sbz132","volume":"46","author":"D Berg\u00e9","year":"2020","unstructured":"Berg\u00e9 D, Man\u00e9 A, Lesh TA, Bioque M, Barcones F, Gonzalez-pinto AM, et al. Elevated extracellular free-water in a multicentric first-episode psychosis sample, decrease during the first 2 years of illness. Schizophr Bull. 2020;46:846\u201356.","journal-title":"Schizophr Bull"},{"key":"3287_CR47","doi-asserted-by":"publisher","first-page":"1413","DOI":"10.1038\/s41386-022-01272-x","volume":"47","author":"I Carreira Figueiredo","year":"2022","unstructured":"Carreira Figueiredo I, Borgan F, Pasternak O, Turkheimer FE, Howes OD. White-matter free-water diffusion MRI in schizophrenia: a systematic review and meta-analysis. Neuropsychopharmacology. 2022;47:1413\u201320.","journal-title":"Neuropsychopharmacology"},{"key":"3287_CR48","doi-asserted-by":"publisher","first-page":"2030","DOI":"10.1038\/s41380-023-02068-1","volume":"28","author":"S Cetin-Karayumak","year":"2023","unstructured":"Cetin-Karayumak S, Lyall AE, Di Biase MA, Seitz-Holland J, Zhang F, Kelly S, et al. Characterization of the extracellular free water signal in schizophrenia using multi-site diffusion MRI harmonization. Mol Psychiatry. 2023;28:2030\u20138.","journal-title":"Mol Psychiatry"},{"key":"3287_CR49","first-page":"17365","volume":"32","author":"O Pasternak","year":"2012","unstructured":"Pasternak O, Westin CF, Bouix S, Seidman LJ, Goldstein JM, Woo T, et al. Excessive extracellular volume reveals a neurodegenerative pattern in schizophrenia onset. Neurobiol Dis. 2012;32:17365\u201372.","journal-title":"Neurobiol Dis"},{"key":"3287_CR50","doi-asserted-by":"publisher","first-page":"1001","DOI":"10.1017\/S0033291719003969","volume":"51","author":"JY Guo","year":"2021","unstructured":"Guo JY, Lesh TA, Niendam TA, Ragland JD, Tully LM, Carter CS. Brain free water alterations in first-episode psychosis: a longitudinal analysis of diagnosis, course of illness, and medication effects. Psychol Med. 2021;51:1001\u201310.","journal-title":"Psychol Med"},{"key":"3287_CR51","first-page":"111","volume":"10","author":"TA Lesh","year":"2024","unstructured":"Lesh TA, Berg\u00e9 D, Smucny J, Guo J, Carter CS. Elevated extracellular free water in the brain predicts clinical improvement in first-episode psychosis. Biol Psychiatry Cogn Neurosci Neuroimaging. 2024;10:111\u20139.","journal-title":"Biol Psychiatry Cogn Neurosci Neuroimaging"},{"key":"3287_CR52","first-page":"22","volume":"59","author":"DV Sheehan","year":"1998","unstructured":"Sheehan DV, Lecrubier Y, Sheehan KH, Amorim P, Janavs J, Weiller E, et al. The Mini-International Neuropsychiatric Interview (M.I.N.I.): the development and validation of a structured diagnostic psychiatric interview for DSM-IV and ICD-10. J Clin Psychiatry. 1998;59:22\u201333.","journal-title":"J Clin Psychiatry"},{"key":"3287_CR53","volume-title":"Four factor index of social status","author":"AB Hollingshead","year":"1975","unstructured":"Hollingshead AB. Four factor index of social status. New Haven: Yale University Department of Psychology; 1975."},{"key":"3287_CR54","doi-asserted-by":"publisher","first-page":"510","DOI":"10.1097\/00005053-199008000-00007","volume":"178","author":"SR Kay","year":"1990","unstructured":"Kay SR, Fiszbein A, Vital-Herne M, Fuentes LS. The positive and negative syndrome scale\u2013Spanish adaptation. J Nerv Ment Dis. 1990;178:510\u20137.","journal-title":"J Nerv Ment Dis"},{"key":"3287_CR55","doi-asserted-by":"publisher","first-page":"88","DOI":"10.1016\/j.schres.2012.10.012","volume":"142","author":"GP Strauss","year":"2012","unstructured":"Strauss GP, Keller WR, Buchanan RW, Gold JM, Fischer BA, McMahon RP, et al. Next-generation negative symptom assessment for clinical trials: validation of the brief negative symptom scale. Schizophr Res. 2012;142:88\u201392.","journal-title":"Schizophr Res"},{"key":"3287_CR56","doi-asserted-by":"publisher","first-page":"1726","DOI":"10.1016\/j.comppsych.2014.05.024","volume":"55","author":"A Man\u00e9","year":"2014","unstructured":"Man\u00e9 A, Garc\u00eda-Rizo C, Garcia-Portilla MP, Berg\u00e9 D, Sugranyes G, Garcia-Alvarez L, et al. Spanish adaptation and validation of the brief negative symptoms scale. Compr Psychiatry. 2014;55:1726\u20139.","journal-title":"Compr Psychiatry"},{"key":"3287_CR57","doi-asserted-by":"publisher","first-page":"815","DOI":"10.2471\/BLT.09.067231","volume":"88","author":"TB \u00dcst\u00fcn","year":"2010","unstructured":"\u00dcst\u00fcn TB, Chatterji S, Kostanjsek N, Rehm J, Kennedy C, Epping-Jordan J, et al. Developing the world health organization disability assessment schedule 2.0. Bull World Health Organ. 2010;88:815\u201323.","journal-title":"Bull World Health Organ"},{"key":"3287_CR58","doi-asserted-by":"publisher","first-page":"105942","DOI":"10.1016\/j.nbd.2022.105942","volume":"176","author":"M Barrera-Conde","year":"2023","unstructured":"Barrera-Conde M, Veza-Est\u00e9vez E, Gomis-Gonzalez M, Garcia-Quintana J, Trabsa A, Mart\u00ednez-Sadurn\u00ed L, et al. Role of cyclin-dependent kinase 5 in psychosis and the modulatory effects of cannabinoids. Neurobiol Dis. 2023;176:105942.","journal-title":"Neurobiol Dis"},{"key":"3287_CR59","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3390\/jpm11030160","volume":"11","author":"M Barrera-Conde","year":"2021","unstructured":"Barrera-Conde M, Ausin K, Lach\u00e9n-Montes M, Fern\u00e1ndez-Irigoyen J, Galindo L, Cuenca-Royo A, et al. Cannabis use induces distinctive proteomic alterations in olfactory neuroepithelial cells of schizophrenia patients. J Pers Med. 2021;11:1\u201316.","journal-title":"J Pers Med"},{"key":"3287_CR60","doi-asserted-by":"publisher","first-page":"101804","DOI":"10.1016\/j.is.2021.101804","volume":"101","author":"E Schubert","year":"2021","unstructured":"Schubert E, Rousseeuw PJ. Fast and eager k-medoids clustering: O(k) runtime improvement of the PAM, CLARA, and CLARANS algorithms. Inf Syst. 2021;101:101804.","journal-title":"Inf Syst"},{"key":"3287_CR61","first-page":"1195","volume":"9","author":"DS Hasin","year":"1996","unstructured":"Hasin DS, Trautman KDSW, Miele GM, Samet S, Smith M, Endicott J. Psychiatric Research Interview for Substance and Mental Disorders (PRISM): reliabilitu for substance abusers. Am J Psychiatry. 1996;9:1195\u2013201.","journal-title":"Am J Psychiatry"},{"key":"3287_CR62","first-page":"76280J","volume":"7628","author":"Z Liu","year":"2010","unstructured":"Liu Z, Wang Y, Gerig G, Gouttard S, Tao R, Fletcher T, et al. Quality control of diffusion weighted images. Proc SPIE\u2013Int Soc Optical Eng. 2010;7628:76280J.","journal-title":"Proc SPIE\u2013Int Soc Optical Eng"},{"key":"3287_CR63","doi-asserted-by":"publisher","first-page":"4","DOI":"10.3389\/fninf.2014.00004","volume":"8","author":"I Oguz","year":"2014","unstructured":"Oguz I, Farzinfar M, Matsui J, Budin F, Liu Z, Gerig G, et al. DTIPrep: quality control of diffusion-weighted images. Front Neuroinform. 2014;8:4.","journal-title":"Front Neuroinform"},{"key":"3287_CR64","doi-asserted-by":"publisher","first-page":"208","DOI":"10.1016\/j.neuroimage.2004.07.051","volume":"23","author":"SM Smith","year":"2004","unstructured":"Smith SM, Jenkinson M, Woolrich MW, Beckmann CF, Behrens TEJ, Johansen-Berg H, et al. Advances in functional and structural MR image analysis and implementation as FSL. Neuroimage. 2004;23:208\u201319.","journal-title":"Neuroimage"},{"key":"3287_CR65","doi-asserted-by":"publisher","first-page":"8","DOI":"10.3389\/fninf.2014.00008","volume":"8","author":"E Garyfallidis","year":"2014","unstructured":"Garyfallidis E, Brett M, Amirbekian B, Rokem A, van der Walt S, Descoteaux M, et al. Dipy, a library for the analysis of diffusion MRI data. Front Neuroinform. 2014;8:8.","journal-title":"Front Neuroinform"},{"key":"3287_CR66","doi-asserted-by":"publisher","first-page":"226","DOI":"10.1016\/j.schres.2018.06.039","volume":"202","author":"M Juncal-Ruiz","year":"2018","unstructured":"Juncal-Ruiz M, Riesco-D\u00e1vila L, Ortiz-Garc\u00eda de la Foz V, Mart\u00ednez-Garcia O, Ram\u00edrez-Bonilla M, Ocejo-Vi\u00f1als JG, et al. Comparison of the anti-inflammatory effect of aripiprazole and risperidone in 75 drug-na\u00efve first episode psychosis individuals: a 3 months randomized study. Schizophr Res. 2018;202:226\u201333.","journal-title":"Schizophr Res"},{"key":"3287_CR67","doi-asserted-by":"publisher","first-page":"2842","DOI":"10.1017\/S0033291721004815","volume":"53","author":"AJ Watson","year":"2023","unstructured":"Watson AJ, Giordano A, Suckling J, Barnes TRE, Husain N, Jones PB, et al. Cognitive function in early-phase schizophrenia-spectrum disorder: IQ subtypes, brain volume and immune markers. Psychol Med. 2023;53:2842\u201351.","journal-title":"Psychol Med"},{"key":"3287_CR68","doi-asserted-by":"publisher","first-page":"1764","DOI":"10.1038\/mp.2017.249","volume":"23","author":"JA Lieberman","year":"2018","unstructured":"Lieberman JA, Girgis RR, Brucato G, Moore H, Provenzano F, Kegeles L, et al. Hippocampal dysfunction in the pathophysiology of schizophrenia: a selective review and hypothesis for early detection and intervention. Mol Psychiatry. 2018;23:1764\u201372.","journal-title":"Mol Psychiatry"},{"key":"3287_CR69","doi-asserted-by":"publisher","first-page":"1246","DOI":"10.1001\/jamapsychiatry.2023.3293","volume":"80","author":"S Chopra","year":"2023","unstructured":"Chopra S, Segal A, Oldham S, Holmes A, Sabaroedin K, Orchard ER, et al. Network-based spreading of gray matter changes across different stages of psychosis. JAMA Psychiatry. 2023;80:1246\u201357.","journal-title":"JAMA Psychiatry"},{"key":"3287_CR70","doi-asserted-by":"publisher","first-page":"269","DOI":"10.1016\/j.bbi.2014.01.018","volume":"40","author":"P Su\u00e1rez-Pinilla","year":"2014","unstructured":"Su\u00e1rez-Pinilla P, L\u00f3pez-Gil J, Crespo-Facorro B. Immune system: a possible nexus between cannabinoids and psychosis. Brain Behav Immun. 2014;40:269\u201382.","journal-title":"Brain Behav Immun"},{"key":"3287_CR71","doi-asserted-by":"publisher","first-page":"400","DOI":"10.1038\/nri1602","volume":"5","author":"TW Klein","year":"2005","unstructured":"Klein TW. Cannabinoid-based drugs as anti-inflammatory therapeutics. Nat Rev Immunol. 2005;5:400\u201311.","journal-title":"Nat Rev Immunol"},{"key":"3287_CR72","doi-asserted-by":"publisher","first-page":"613613","DOI":"10.3389\/fimmu.2020.613613","volume":"11","author":"SV Suryavanshi","year":"2021","unstructured":"Suryavanshi SV, Kovalchuk I, Kovalchuk O. Cannabinoids as key regulators of inflammasome signaling: a current perspective. Front Immunol. 2021;11:613613.","journal-title":"Front Immunol"},{"key":"3287_CR73","doi-asserted-by":"publisher","first-page":"1305","DOI":"10.1001\/jamapsychiatry.2019.2516","volume":"76","author":"T Da Silva","year":"2019","unstructured":"Da Silva T, Hafizi S, Watts JJ, Weickert CS, Meyer JH, Houle S, et al. In vivo imaging of translocator protein in long-term cannabis users. JAMA Psychiatry. 2019;76:1305\u201313.","journal-title":"JAMA Psychiatry"},{"key":"3287_CR74","doi-asserted-by":"publisher","first-page":"275","DOI":"10.1016\/j.schres.2017.08.027","volume":"195","author":"BJ Miller","year":"2018","unstructured":"Miller BJ, Buckley PF, McEvoy JP. Inflammation, substance use, psychopathology, and cognition in phase 1 of the clinical antipsychotic trials of intervention effectiveness study. Schizophr Res. 2018;195:275\u201382.","journal-title":"Schizophr Res"},{"key":"3287_CR75","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1080\/15504263.2021.2013697","volume":"18","author":"B Romeo","year":"2022","unstructured":"Romeo B, Lestra V, Martelli C, Benyamina A, Hamdani N. Cannabis cessation, inflammatory markers and schizophrenia. J Dual Diagn. 2022;18:33\u201341.","journal-title":"J Dual Diagn"},{"key":"3287_CR76","doi-asserted-by":"publisher","first-page":"118","DOI":"10.1017\/neu.2023.24","volume":"36","author":"B Romeo","year":"2023","unstructured":"Romeo B, Lestra V, Martelli C, Amirouche A, Benyamina A, Hamdani N. Increased markers of inflammation after cannabis cessation, and their association with psychotic symptoms. Acta Neuropsychiatr. 2023;36:118\u201327.","journal-title":"Acta Neuropsychiatr"},{"key":"3287_CR77","doi-asserted-by":"publisher","first-page":"633","DOI":"10.1097\/NMD.0000000000001019","volume":"207","author":"RL Goetz","year":"2019","unstructured":"Goetz RL, Miller BJ. Total and differential white blood cell counts, cocaine, and marijuana use in patients with schizophrenia. J Nerv Ment Dis. 2019;207:633\u20136.","journal-title":"J Nerv Ment Dis"},{"key":"3287_CR78","doi-asserted-by":"publisher","first-page":"90","DOI":"10.1016\/j.bbi.2012.06.010","volume":"31","author":"M Di Nicola","year":"2013","unstructured":"Di Nicola M, Cattaneo A, Hepgul N, Di Forti M, Aitchison KJ, Janiri L, et al. Serum and gene expression profile of cytokines in first-episode psychosis. Brain Behav Immun. 2013;31:90\u20135.","journal-title":"Brain Behav Immun"},{"key":"3287_CR79","doi-asserted-by":"publisher","first-page":"3874","DOI":"10.1017\/S0033291721000726","volume":"52","author":"F Corsi-Zuelli","year":"2022","unstructured":"Corsi-Zuelli F, Marques L, da Roza DL, Loureiro CM, Shuhama R, Di Forti MD, et al. The independent and combined effects of cannabis use and systemic inflammation during the early stages of psychosis: exploring the two-hit hypothesis. Psychol Med. 2022;52:3874\u201384.","journal-title":"Psychol Med"},{"key":"3287_CR80","doi-asserted-by":"publisher","first-page":"54","DOI":"10.1097\/HRP.0000000000000323","volume":"30","author":"CE Millett","year":"2022","unstructured":"Millett CE, Burdick KE, Kubicki MR. The effects of peripheral inflammation on the brain-a neuroimaging perspective. Harv Rev Psychiatry. 2022;30:54\u20138.","journal-title":"Harv Rev Psychiatry"},{"key":"3287_CR81","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1016\/j.ejim.2018.01.004","volume":"49","author":"CA MacCallum","year":"2018","unstructured":"MacCallum CA, Russo EB. Practical considerations in medical cannabis administration and dosing. Eur J Intern Med. 2018;49:12\u20139.","journal-title":"Eur J Intern Med"},{"key":"3287_CR82","doi-asserted-by":"publisher","first-page":"sgaa014","DOI":"10.1093\/schizbullopen\/sgaa014","volume":"1","author":"MB Thies","year":"2020","unstructured":"Thies MB, DeRosse P, Sarpal DK, Argyelan M, Fales CL, Gallego JA, et al. Interaction of cannabis use disorder and striatal connectivity in antipsychotic treatment response. Schizophr Bull Open. 2020;1:sgaa014.","journal-title":"Schizophr Bull Open"},{"key":"3287_CR83","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1016\/j.schres.2022.02.026","volume":"243","author":"M Bioque","year":"2022","unstructured":"Bioque M, Mezquida G, Amoretti S, Man A, Usall J, Contreras F, et al. Clinical and treatment predictors of relapse during a three-year follow-up of a cohort of first episodes of schizophrenia. Schizophr Res. 2022;243:32\u201342.","journal-title":"Schizophr Res"},{"key":"3287_CR84","doi-asserted-by":"publisher","first-page":"1055481","DOI":"10.3389\/fpsyt.2022.1055481","volume":"13","author":"RT Smith","year":"2023","unstructured":"Smith RT, Gruber SA. Contemplating cannabis? the complex relationship between cannabinoids and hepatic metabolism resulting in the potential for drug-drug interactions. Front Psychiatry. 2023;13:1055481.","journal-title":"Front Psychiatry"},{"key":"3287_CR85","doi-asserted-by":"publisher","first-page":"1547","DOI":"10.1093\/schbul\/sbaa038","volume":"46","author":"D Guinart","year":"2020","unstructured":"Guinart D, Moreno E, Galindo L, Cuenca-Royo A, Barrera-Conde M, P\u00e9rez EJ, et al. Altered signaling in CB1R-5-HT2AR heteromers in olfactory neuroepithelium cells of schizophrenia patients is modulated by cannabis use. Schizophr Bull. 2020;46:1547\u201357.","journal-title":"Schizophr Bull"},{"key":"3287_CR86","doi-asserted-by":"publisher","first-page":"303","DOI":"10.1016\/j.pnpbp.2008.12.006","volume":"33","author":"H Sugino","year":"2009","unstructured":"Sugino H, Futamura T, Mitsumoto Y, Maeda K, Marunaka Y. Atypical antipsychotics suppress production of proinflammatory cytokines and up-regulate interleukin-10 in lipopolysaccharide-treated mice. Prog Neuropsychopharmacol Biol Psychiatry. 2009;33:303\u20137.","journal-title":"Prog Neuropsychopharmacol Biol Psychiatry"},{"key":"3287_CR87","doi-asserted-by":"publisher","first-page":"663","DOI":"10.1016\/j.biopsych.2011.04.013","volume":"70","author":"BJ Miller","year":"2011","unstructured":"Miller BJ, Buckley P, Seabolt W, Mellor A, Kirkpatrick B. Meta-analysis of cytokine alterations in schizophrenia: clinical status and antipsychotic effects. Biol Psychiatry. 2011;70:663\u201371.","journal-title":"Biol Psychiatry"},{"key":"3287_CR88","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1016\/j.schres.2020.01.003","volume":"226","author":"S Kelsven","year":"2020","unstructured":"Kelsven S, de la Fuente-Sandoval C, Achim CL, Reyes-Madrigal F, Mirzakhanian H, Domingues I, et al. Immuno-inflammatory changes across phases of early psychosis: the impact of antipsychotic medication and stage of illness. Schizophr Res. 2020;226:13\u201323.","journal-title":"Schizophr Res"},{"key":"3287_CR89","doi-asserted-by":"publisher","first-page":"2488","DOI":"10.3390\/jcm10112488","volume":"10","author":"P Marcinowicz","year":"2021","unstructured":"Marcinowicz P, Wi\u0119d\u0142ocha M, Zborowska N, D\u0119bowska W, Podwalski P, Misiak B, et al. A meta-analysis of the influence of antipsychotics on cytokines levels in first episode psychosis. J Clin Med. 2021;10:2488.","journal-title":"J Clin Med"},{"key":"3287_CR90","doi-asserted-by":"crossref","unstructured":"Forti M Di, Sallis H, Allegri F, Trotta A, Ferraro L, Stilo SA, et al. Daily use, especially of high-potency cannabis, drives the earlier onset of psychosis in cannabis users. Schizophr Bull. 2013;40:1509\u201317.","DOI":"10.1093\/schbul\/sbt181"},{"key":"3287_CR91","first-page":"1","volume":"0366","author":"T Schoeler","year":"2016","unstructured":"Schoeler T, Petros N, Di Forti M, Klamerus E, Foglia E, Ajnakina O, et al. Effects of continuation, frequency, and type of cannabis use on relapse in the fi rst 2 years after onset of psychosis: an observational study. Lancet Psychiatry. 2016;0366:1\u20137.","journal-title":"Lancet Psychiatry"},{"key":"3287_CR92","doi-asserted-by":"publisher","first-page":"764","DOI":"10.1038\/npp.2009.184","volume":"35","author":"S Bhattacharyya","year":"2010","unstructured":"Bhattacharyya S, Morrison PD, Fusar-Poli P, Martin-Santos R, Borgwardt S, Winton-Brown T, et al. Opposite effects of \u03b4-9-tetrahydrocannabinol and cannabidiol on human brain function and psychopathology. Neuropsychopharmacology. 2010;35:764\u201374.","journal-title":"Neuropsychopharmacology"}],"container-title":["Molecular Psychiatry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41380-025-03287-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41380-025-03287-4","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41380-025-03287-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,12,12]],"date-time":"2025-12-12T12:03:57Z","timestamp":1765541037000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41380-025-03287-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,10,7]]},"references-count":92,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2026,1]]}},"alternative-id":["3287"],"URL":"https:\/\/doi.org\/10.1038\/s41380-025-03287-4","relation":{},"ISSN":["1359-4184","1476-5578"],"issn-type":[{"type":"print","value":"1359-4184"},{"type":"electronic","value":"1476-5578"}],"subject":[],"published":{"date-parts":[[2025,10,7]]},"assertion":[{"value":"4 November 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 August 2025","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 September 2025","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 October 2025","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"All methods were performed in accordance with relevant guidelines and regulations. The study was approved by the Clinical Research Ethics Committee of Hospital del Mar (reference number 2018\/7942\/I). Written informed consent was obtained from all participants prior to inclusion in the study.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}}]}}